Navigation Links
Merge Healthcare appoints new CEO, reports $215 million Q2 loss

West Allis, Wis. - Merge Healthcare, a supplier of medical imaging and information technology, has appointed a new company leader and reported a $215.8 million quarterly loss.

Kenneth Rardin has assumed the role of president and CEO of the financially troubled company, replacing interim CEO Michael Dunham, chairman of the board of direc......

Full article >>> any, claiming it issued false statements in its 2005 purchase of Cedara Software for $325 million. The suit sparked an investigation that led to the discovery of material errors in its financial statements, followed by the resignations of top executives, including company founder Bill Mortimore. Last week, the company acknowledged that former executives did not......

Full article >>> n added.

IMNET was investigated after anonymous letters were sent to its auditors, and it underwent an "informal inquiry" from the U.S. Securities and Exchange Commission.

The investigation had "significant" short-term revenue impacts on the company due to the unknowns caused by the late filing and the ongoing negative comments by its competitors......

Full article >>>
'"/> By Chris Fleissner 09/06/06

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Merge Technologies net loss doubles to $10.1M
3. Merge unveils next-generation imaging-informatics product
4. Merge unveils updated medical imaging software
5. Merge Healthcare suffers $258M loss in `06
6. Merge Healthcare unveils diagnostic mammography tool
7. Merge Healthcare promotes Bowers to president
8. Merge Healthcare hires new VP of finance
9. Merge offshoring jobs to "more cost-effective" workforce
10. Merge Healthcare reports $10.8M net loss in Q3
11. Merge eMed releases software upgrade
Post Your Comments:

(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a ... their partnership with the Keck Medicine of the University of Southern California ... T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... engaged in developing and commercializing novel treatments in oncology, ... Dennis Turpin , the Company,s former Senior Vice ... its Quebec City office.  ... Chief Executive Officer of the Company commented, "After a ...
(Date:10/12/2015)... ... October 12, 2015 , ... Dr. Carl Peck, MD, Chairman ... firm as a Premier Expert consultant. NDA Partners Premier Experts are top ... to the company's clients. Premier Experts collaborate to design and implement critical ...
Breaking Biology Technology:
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/28/2015)... , September 28, 2015 According ... (Hardware & Software), Product (Scanner & Others), Application (Access ... Defense, & Others) & Geography Global - Forecast to ... to reach USD 3627.90 Million by 2020, at a ... Browse 65 market data T ables and ...
Breaking Biology News(10 mins):